Detalhe da pesquisa
1.
Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanisms.
J Immunol
; 184(11): 6035-42, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20421646
2.
Implication of complement system and its regulators in Alzheimer's disease.
Curr Neuropharmacol
; 7(1): 1-8, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19721814
3.
Retraction. Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanisms.
J Immunol
; 187(12): 6581, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22158336
4.
Asparaginyl Endopeptidase (Legumain) Supports Human Th1 Induction via Cathepsin L-Mediated Intracellular C3 Activation.
Front Immunol
; 9: 2449, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405635